Directory
>
Gunaretnam Rajagopal
Gunaretnam Rajagopal
Venture Partner | The Janssen Pharmaceutical Companies of Johnson & Johnson
Pennsylvania, United States
Gunaretnam Rajagopal
Summary
Gunaretnam Rajagopal is a seasoned Venture Partner at Samsara BioCapital, focusing on innovative approaches in biotechnology and pharmaceuticals, particularly leveraging AI and genomics in drug discovery. With a robust background in computational sciences and a history of leadership at major pharmaceutical companies like Johnson & Johnson, he has a proven track record of guiding multidisciplinary teams in transforming complex biomedical data into actionable insights. His work spans various domains, including cancer research, gene therapy, and systems biology, often intersecting with cutting-edge technologies. Gunaretnam has also contributed significantly to academia as an adjunct professor, shaping the next generation of scientists. His extensive experience in building cyber-infrastructure for clinical research showcases his commitment to advancing healthcare through technology. In addition, his publications reflect a deep engagement with the scientific community, addressing critical issues in precision medicine. Gunaretnam's unique blend of scientific expertise and leadership acumen positions him as a thought leader in the biotech space.
Gunaretnam Rajagopal
Work Experience
Venture Partner at
Samsara BioCapital
September 2022 - Present
VP - Global Head, Computational Sciences, Discovery Sciences at
The Janssen Pharmaceutical Companies of Johnson & Johnson
September 2013 - Present
Scientific Vice President & Fellow, Computational Sciences at
The Janssen Pharmaceutical Companies of Johnson & Johnson
June 2021 - September 2022
Adjunct Professor, Radiation Oncology at
Rutgers Cancer Institute
September 2009 - March 2016
VP & CIO - Research, Bioinformatics & External Innovation at
The Janssen Pharmaceutical Companies of Johnson & Johnson
June 2012 - September 2013
Executive Director (Bioinformatics) at
The Cancer Institute of New Jersey
September 2007 - August 2012
Member at
Institute For Advanced Study Princeton
September 2008 - September 2010
Executive Director, at
BIOINFORMATICS INSTITUTE
June 2001 - September 2007
Fellow and Director of Studies (Physics) at
JESUS COLLEGE CAMBRIDGE
January 1996 - January 2001
Assist. Director Of Research, Theory of Condensed Matter Group at
Cavendish Laboratory University Of Cambridge
January 1996 - January 2001
Gunaretnam Rajagopal
Education
Georgia Institute of Technology, Phd
January 1987 - January 1991
university malaya, Msc
January 1981 - January 1983
university malaya, Bsced/Msc
January 1977 - January 1981
Frequently Asked Questions about Gunaretnam Rajagopal
What is Gunaretnam Rajagopal email address?
Gunaretnam Rajagopal's primary email address is **********@jnj.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Gunaretnam Rajagopal work for?
Gunaretnam Rajagopal is a Venture Partner at The Janssen Pharmaceutical Companies of Johnson & Johnson, a company specializing in Pharmaceutical & Medicine Manufacturing.
Where Gunaretnam Rajagopal graduated from?
Gunaretnam Rajagopal holds a degree in Theoretical & Computational Condensed Matter Physics from Georgia Institute of Technology.
How can I directly contact Gunaretnam Rajagopal?
To contact Gunaretnam Rajagopal directly, you can use the email address **********@jnj.com. Complete contact information is available upon registration with Muraena.
Who is Gunaretnam Rajagopal?
Gunaretnam Rajagopal is a seasoned Venture Partner at Samsara BioCapital, focusing on innovative approaches in biotechnology and pharmaceuticals, particularly leveraging AI and genomics in drug discovery. With a robust background in computational sciences and a history of leadership at major pharmaceutical companies like Johnson & Johnson, he has a proven track record of guiding multidisciplinary teams in transforming complex biomedical data into actionable insights. His work spans various domains, including cancer research, gene therapy, and systems biology, often intersecting with cutting-edge technologies. Gunaretnam has also contributed significantly to academia as an adjunct professor, shaping the next generation of scientists. His extensive experience in building cyber-infrastructure for clinical research showcases his commitment to advancing healthcare through technology. In addition, his publications reflect a deep engagement with the scientific community, addressing critical issues in precision medicine. Gunaretnam's unique blend of scientific expertise and leadership acumen positions him as a thought leader in the biotech space.
Gunaretnam`s contact details
**********@jnj.com
********@umdnj.edu
********@its.jnj.com
**********@ias.edu
**********@samsaracap.com
Colleagues
VP of Innovation and Technology Deployment, Janssen Supply Chain
VP, Disease Area Stronghold Lead, Neurodegeneration
Director IT
Vice President Clinical Development, Solid Tumor Franchise
CIO & VP of Business Technology
Executive Sales Representative
Managing Director - the Netherlands
Vice President, Communications, The Americas
Compound Development Leader
Vice President- Global Neuroscience, Infectious Disease, Vaccines and GPH Regulatory Head